Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger
Nina Dominik
Michael Trauner

Showing results (1-10 of 1,016) with videos related to

Pageof 102
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2025
ReplyThomas Reiberger, Nina Dominik, Michael Trauner
Hepatology (Baltimore, Md.)|July 12, 2022
ReplyLukas Hartl, Thomas Reiberger, Michael Trauner
Alimentary Pharmacology & Therapeutics|September 23, 2021
Review article: therapeutic aspects of bile acid signalling in the gut-liver axisBenedikt Simbrunner, Michael Trauner, Thomas Reiberger
Hepatology (Baltimore, Md.)|April 10, 2023
Reply: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Thomas Reiberger, Michael Trauner
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
World Journal of Gastroenterology|October 30, 2019
Gut-liver axis signaling in portal hypertensionBenedikt Simbrunner, Mattias Mandorfer, Michael Trauner, et al.
Hepatology (Baltimore, Md.)|September 19, 2025
Bile acid signaling in MASLD: From pathogenesis to therapeutic applicationsBenedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, et al.
Faculty Reviews|June 16, 2021
Recent advances in the understanding and management of hepatorenal syndromeBenedikt Simbrunner, Michael Trauner, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 14, 2025
Elevated Hepatic Copper Content in Porto-Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong TrackLorenz Balcar, Nina Dominik, Behrang Mozayani, et al.
Hepatology (Baltimore, Md.)|September 17, 2016
Liver Capsule: FXR agonists against liver diseaseClaudia D Fuchs, Philipp Schwabl, Thomas Reiberger, et al.
Pageof 102

Showing results (1-10 of 1,016) with videos related to

Sort By:
Pageof 102
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 11, 2025
ReplyThomas Reiberger, Nina Dominik, Michael Trauner
Hepatology (Baltimore, Md.)|July 12, 2022
ReplyLukas Hartl, Thomas Reiberger, Michael Trauner
Alimentary Pharmacology & Therapeutics|September 23, 2021
Review article: therapeutic aspects of bile acid signalling in the gut-liver axisBenedikt Simbrunner, Michael Trauner, Thomas Reiberger
Hepatology (Baltimore, Md.)|April 10, 2023
Reply: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Thomas Reiberger, Michael Trauner
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
World Journal of Gastroenterology|October 30, 2019
Gut-liver axis signaling in portal hypertensionBenedikt Simbrunner, Mattias Mandorfer, Michael Trauner, et al.
Hepatology (Baltimore, Md.)|September 19, 2025
Bile acid signaling in MASLD: From pathogenesis to therapeutic applicationsBenedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, et al.
Faculty Reviews|June 16, 2021
Recent advances in the understanding and management of hepatorenal syndromeBenedikt Simbrunner, Michael Trauner, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 14, 2025
Elevated Hepatic Copper Content in Porto-Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong TrackLorenz Balcar, Nina Dominik, Behrang Mozayani, et al.
Hepatology (Baltimore, Md.)|September 17, 2016
Liver Capsule: FXR agonists against liver diseaseClaudia D Fuchs, Philipp Schwabl, Thomas Reiberger, et al.
Pageof 102